Furthermore, lncRNA-BGL3 was highly induced in response to the disruption of BCR-ABL1 expression, or by inhibiting BCR-ABL1 kinase activity in K562 cells and leukemic cells derived from CML patients. This evidence concerns the gene BGLT3 and chronic myelogenous leukemia, BCR-ABL1 positive.